Department of Surgery, Yamaga City Medical Center, Yamaga, Japan.
Department of Gastroenterological Surgery, Graduate School of Life Sciences, Kumamoto University, Kumamoto, Japan.
J Surg Oncol. 2024 Apr;129(5):893-900. doi: 10.1002/jso.27590. Epub 2024 Jan 18.
The annual postoperative disease-free survival for colorectal liver metastases can be easily estimated by weighting six preoperative clinical parameters (Beppu score). We identified three recurrence-risk stratification groups: the low (≤6 points), moderate (7-10 points), and high-risk (≥11 points). For low-, moderate-, and high-risk patients, hepatectomy alone, hepatectomy with adjuvant chemotherapy, and hepatectomy with preoperative chemotherapy are recommended, respectively. The Beppu score enables the decision on the necessity and timing of perioperative chemotherapy.
结直肠肝转移术后无病生存率可通过对术前 6 项临床参数(贝普评分)进行加权计算来进行简单预测。我们确定了三个复发风险分层组:低危(≤6 分)、中危(7-10 分)和高危(≥11 分)。对于低危、中危和高危患者,分别推荐单独肝切除术、肝切除术联合辅助化疗和肝切除术联合术前化疗。贝普评分有助于决定围手术期化疗的必要性和时机。